|Student Contribution Band:||Band 2|
|Administered by:||College of Medicine & Dentistry|
Available to students enrolled in level 3 of the Bachelor of Pharmacy.
Cardiovascular disease is the major cause of morbidity and mortality in the Australian population and renal disease is of high prevalence in tropical areas and indigenous populations. This subject will address the incidence, causative factors, pathophysiology, therapeutics and prevention of cardiovascular and renal problems relevant to pharmacy practice. An emphasis will be placed on an understanding of the Quality Use of Medicines (QUM) with particular relevance to issues experienced by older Australians, indigenous and rural populations. The student will also be exposed to transplant medicine and how pharmacists can assist with determining appropriate drug regimens used in these patients.
|Prerequisites:||All level 2 BPharm subjects|
|PP2231 and PP3251 and PP3252|
|Townsville, Study Period 1, Internal|
|Census Date 28-Mar-2019|
|Coordinator:||Assoc. Professor Ian Heslop|
|Lecturers:||Assoc. Professor Ian Heslop, Professor Beverley Glass.|
The student workload for this 3 credit point subject is approximately 130 hours.
|Assessment:||end of semester exam (60%); osce (25%); on-course assessment (15%).|
Note: Minor variations might occur due to the continuous Subject quality improvement process, and in case of minor variation(s) in assessment details, the Subject Outline represents the latest official information.